Efficacy and Safety of Rivaroxaban for the Prevention of Stroke in Subjects With Non-Valvular Atrial Fibrillation

Completed

Phase 3 Results

Summary of Purpose

This is a clinical study evaluating the efficacy and safety of rivaroxaban for stroke prevention in patients with atrial fibrillation (originally described in Japanese).

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 1 April 2015.

1 Jun 2007 29 Jun 2007 1 Dec 2009 1 Jan 2010 1 Apr 2015 28 Mar 2012
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Caregiver, Investigator)
  • Purpose: Prevention
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment

Contacts

Not available